Associations of plasma homocysteine and the methylenetetrahydrofolate reductase C677T polymorphism with carotid intima media thickness among South Asian, Chinese and European Canadians.

[1]  S. Yusuf,et al.  Development and evaluation of cultural food frequency questionnaires for South Asians, Chinese, and Europeans in North America. , 2003, Journal of the American Dietetic Association.

[2]  Petra Verhoef,et al.  MTHFR 677C-->T polymorphism and risk of coronary heart disease: a meta-analysis. , 2002, JAMA.

[3]  Per Magne Ueland,et al.  Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis. , 2002, JAMA.

[4]  P. Wilson,et al.  Determinants of plasma total homocysteine concentration in the Framingham Offspring cohort. , 2001, The American journal of clinical nutrition.

[5]  G. Coetzee,et al.  Genetic, dietary, and other lifestyle determinants of plasma homocysteine concentrations in middle-aged and older Chinese men and women in Singapore. , 2001, The American journal of clinical nutrition.

[6]  S. Yusuf,et al.  Differences in risk factors, atherosclerosis, and cardiovascular disease between ethnic groups in Canada: the Study of Health Assessment and Risk in Ethnic groups (SHARE) , 2000, The Lancet.

[7]  D O Stram,et al.  A multiethnic cohort in Hawaii and Los Angeles: baseline characteristics. , 2000, American journal of epidemiology.

[8]  John C Chambers,et al.  Plasma homocysteine concentrations and risk of coronary heart disease in UK Indian Asian and European men , 2000, The Lancet.

[9]  K. Hughes,et al.  Homocysteine, folate, vitamin B12, and cardiovascular risk in Indians, Malays, and Chinese in Singapore , 2000, Journal of epidemiology and community health.

[10]  S. Ebrahim,et al.  Serum total homocysteine and coronary heart disease: prospective study in middle aged men , 1999, Heart.

[11]  S. Yusuf,et al.  Cardiovascular and cancer mortality among Canadians of European, south Asian and Chinese origin from 1979 to 1993: an analysis of 1.2 million deaths. , 1999, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

[12]  R. D'Agostino,et al.  Nonfasting plasma total homocysteine levels and all-cause and cardiovascular disease mortality in elderly Framingham men and women. , 1999, Archives of internal medicine.

[13]  J. Manson,et al.  Homocysteine and risk of cardiovascular disease among postmenopausal women. , 1999, JAMA.

[14]  J. Beilby,et al.  Hyperhomocysteinemia but not the C677T mutation of methylenetetrahydrofolate reductase is an independent risk determinant of carotid wall thickening. The Perth Carotid Ultrasound Disease Assessment Study (CUDAS) , 1999, Circulation.

[15]  A J Marian,et al.  Plasma homocyst(e)ine concentration, but not MTHFR genotype, is associated with variation in carotid plaque area. , 1999, Stroke.

[16]  A. Hoes,et al.  Homocysteine and short-term risk of myocardial infarction and stroke in the elderly: the Rotterdam Study. , 1999, Archives of internal medicine.

[17]  R. Matthews,et al.  The structure and properties of methylenetetrahydrofolate reductase from Escherichia coli suggest how folate ameliorates human hyperhomocysteinemia , 1999, Nature Structural Biology.

[18]  D Kromhout,et al.  Serum homocysteine and risk of coronary heart disease and cerebrovascular disease in elderly men: a 10-year follow-up. , 1998, Arteriosclerosis, thrombosis, and vascular biology.

[19]  S. Yusuf,et al.  The Study of Health Assessment and Risk in Ethnic groups (SHARE): rationale and design. The SHARE Investigators. , 1998, The Canadian journal of cardiology.

[20]  P. Elwood,et al.  Homocysteine and ischaemic heart disease in the Caerphilly cohort. , 1998, Atherosclerosis.

[21]  A. Folsom,et al.  Prospective study of coronary heart disease incidence in relation to fasting total homocysteine, related genetic polymorphisms, and B vitamins: the Atherosclerosis Risk in Communities (ARIC) study. , 1998, Circulation.

[22]  M. Law,et al.  Homocysteine and ischemic heart disease: results of a prospective study with implications regarding prevention. , 1998, Archives of internal medicine.

[23]  S. Vollset,et al.  Plasma homocysteine levels and mortality in patients with coronary artery disease. , 1997, The New England journal of medicine.

[24]  Sonia S Anand,et al.  Classifying ethnicity utilizing the Canadian Mortality Data Base. , 1997, Ethnicity and Health.

[25]  J. Cutler,et al.  Homocyst(e)ine and risk of cardiovascular disease in the Multiple Risk Factor Intervention Trial. , 1997, Arteriosclerosis, thrombosis, and vascular biology.

[26]  A. Folsom,et al.  Association of coronary heart disease incidence with carotid arterial wall thickness and major risk factors: the Atherosclerosis Risk in Communities (ARIC) Study, 1987-1993. , 1997, American journal of epidemiology.

[27]  K. Alberti,et al.  Identifying Chinese populations in the UK for epidemiological research: experience of a name analysis of the FHSA register. Family Health Services Authority. , 1997, Public health.

[28]  J. Witteman,et al.  Plasma homocysteine as a risk factor for vascular disease. The European Concerted Action Project. , 1997, JAMA.

[29]  J. Witteman,et al.  Plasma total homocysteine, B vitamins, and risk of coronary atherosclerosis. , 1997, Arteriosclerosis, thrombosis, and vascular biology.

[30]  W. Willett,et al.  Plasma total homocysteine and risk of angina pectoris with subsequent coronary artery bypass surgery. , 1997, The American journal of cardiology.

[31]  P. Frosst,et al.  Correlation of a common mutation in the methylenetetrahydrofolate reductase gene with plasma homocysteine in patients with premature coronary artery disease. , 1997, Arteriosclerosis, thrombosis, and vascular biology.

[32]  W. Willett,et al.  Methylenetetrahydrofolate reductase polymorphism, plasma folate, homocysteine, and risk of myocardial infarction in US physicians. , 1996, Circulation.

[33]  I. Rosenberg,et al.  Plasma homocysteine as a risk factor for atherothrombotic events in systemic lupus erythematosus , 1996, The Lancet.

[34]  D. Arveiler,et al.  Plasma homocyst(e)ine levels and graded risk for myocardial infarction: findings in two populations at contrasting risk for coronary heart disease. , 1996, Atherosclerosis.

[35]  W. Willett,et al.  A prospective study of folate and vitamin B6 and risk of myocardial infarction in US physicians. , 1996, Journal of the American College of Nutrition.

[36]  I. Rosenberg,et al.  Relation between folate status, a common mutation in methylenetetrahydrofolate reductase, and plasma homocysteine concentrations. , 1996, Circulation.

[37]  David P Miller,et al.  Hyperhomocysteinemia and low pyridoxal phosphate. Common and independent reversible risk factors for coronary artery disease. , 1995, Circulation.

[38]  S. Hunt,et al.  Higher plasma homocyst(e)ine and increased susceptibility to adverse effects of low folate in early familial coronary artery disease. , 1995, Arteriosclerosis, thrombosis, and vascular biology.

[39]  K. Bønaa,et al.  Serum total homocysteine and coronary heart disease. , 1995, International journal of epidemiology.

[40]  J. Selhub,et al.  Homocysteine and coronary artery disease in French Canadian subjects: relation with vitamins B12, B6, pyridoxal phosphate, and folate. , 1995, The American journal of cardiology.

[41]  J. Genest,et al.  Measurement of homocyst(e)ine in the prediction of arteriosclerosis. , 1995, Clinical biochemistry.

[42]  R. D'Agostino,et al.  Association between plasma homocysteine concentrations and extracranial carotid-artery stenosis. , 1995, The New England journal of medicine.

[43]  R. Matthews,et al.  A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase , 1995, Nature Genetics.

[44]  J. Salonen,et al.  Relation of serum homocysteine and lipoprotein(a) concentrations to atherosclerotic disease in a prospective Finnish population based study. , 1994, Atherosclerosis.

[45]  L. Chambless,et al.  Carotid artery intimal-medial wall thickening and plasma homocyst(e)ine in asymptomatic adults. The Atherosclerosis Risk in Communities Study. , 1993, Circulation.

[46]  W. Willett,et al.  Comparison of micronutrient intake measured by a dietary questionnaire and biochemical indicators of micronutrient status. , 1993, The American journal of clinical nutrition.

[47]  W. Willett,et al.  A prospective study of plasma homocyst(e)ine and risk of myocardial infarction in US physicians. , 1992, JAMA.

[48]  S. S. Kang,et al.  Intermediate homocysteinemia: a thermolabile variant of methylenetetrahydrofolate reductase. , 1988, American journal of human genetics.

[49]  Meir J. Stampfer,et al.  Total energy intake: implications for epidemiologic analyses. , 1986, American journal of epidemiology.

[50]  D. Kleinbaum,et al.  Applied Regression Analysis and Other Multivariate Methods , 1978 .